Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

Molecular Characterization of Near Full-Length Genomes of Hepatitis B Virus Isolated from Predominantly HIV Infected Individuals in Botswana.

Anderson M, Choga WT, Moyo S, Bell TG, Mbangiwa T, Phinius BB, Bhebhe L, Sebunya TK, Lockman S, Marlink R, Kramvis A, Essex M, Musonda RM, Blackard JT, Gaseitsiwe S.

Genes (Basel). 2018 Sep 7;9(9). pii: E453. doi: 10.3390/genes9090453.

2.

In Silico Analysis of Hepatitis B Virus Occult Associated Mutations in Botswana Using a Novel Algorithm.

Anderson M, Choga WT, Moyo S, Bell TG, Mbangiwa T, Phinius BB, Bhebhe L, Sebunya TK, Makhema J, Marlink R, Kramvis A, Essex M, Musonda RM, Blackard JT, Gaseitsiwe S.

Genes (Basel). 2018 Aug 21;9(9). pii: E420. doi: 10.3390/genes9090420.

3.

Correction: Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana.

Mupfumi L, Moyo S, Molebatsi K, Thami PK, Anderson M, Mogashoa T, Iketleng T, Makhema J, Marlink R, Kasvosve I, Essex M, Musonda RM, Gaseitsiwe S.

PLoS One. 2018 Jun 1;13(6):e0198711. doi: 10.1371/journal.pone.0198711. eCollection 2018.

4.

Prevalence of Rilpivirine and Etravirine Resistance Mutations in HIV-1 Subtype C-Infected Patients Failing Nevirapine or Efavirenz-Based Combination Antiretroviral Therapy in Botswana.

Diphoko T, Gaseitsiwe S, Kasvosve I, Moyo S, Okatch H, Musonda R, Wainberg M, Makhema J, Marlink R, Novitsky V, Essex M.

AIDS Res Hum Retroviruses. 2018 Aug;34(8):667-671. doi: 10.1089/AID.2017.0135. Epub 2018 Jun 12.

PMID:
29732907
5.

Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana.

Mupfumi L, Moyo S, Molebatsi K, Thami PK, Anderson M, Mogashoa T, Iketleng T, Makhema J, Marlink R, Kasvosve I, Essex M, Musonda RM, Gaseitsiwe S.

PLoS One. 2018 Jan 31;13(1):e0192030. doi: 10.1371/journal.pone.0192030. eCollection 2018. Erratum in: PLoS One. 2018 Jun 1;13(6):e0198711.

6.

The Impact of Human Pegivirus on CD4 Cell Count in HIV-Positive Persons in Botswana.

N'Guessan KF, Anderson M, Phinius B, Moyo S, Malick A, Mbangiwa T, Choga WT, Makhema J, Marlink R, Essex M, Musonda R, Gaseitsiwe S, Blackard JT.

Open Forum Infect Dis. 2017 Oct 10;4(4):ofx222. doi: 10.1093/ofid/ofx222. eCollection 2017 Fall.

7.

The effect of micronutrient supplementation on active TB incidence early in HIV infection in Botswana.

Campa A, Baum MK, Bussmann H, Martinez SS, Farahani M, van Widenfelt E, Moyo S, Makhema J, Essex M, Marlink R.

Nutr Diet Suppl. 2017;2017(9):37-45. doi: 10.2147/NDS.S123545. Epub 2017 Jul 14.

8.

High Rates of Occult Hepatitis B Virus Infection in HIV-Positive Individuals Initiating Antiretroviral Therapy in Botswana.

Ryan K, Anderson M, Gyurova I, Ambroggio L, Moyo S, Sebunya T, Makhema J, Marlink R, Essex M, Musonda R, Gaseitsiwe S, Blackard JT.

Open Forum Infect Dis. 2017 Sep 13;4(4):ofx195. doi: 10.1093/ofid/ofx195. eCollection 2017 Fall.

9.

Urgently Creating the Better in Global Health.

Marlink R.

Hastings Cent Rep. 2017 Sep;47(5):25-26. doi: 10.1002/hast.765.

PMID:
28940350
10.

Genome-Wide Analyses Reveal Gene Influence on HIV Disease Progression and HIV-1C Acquisition in Southern Africa.

Xie W, Agniel D, Shevchenko A, Malov SV, Svitin A, Cherkasov N, Baum MK, Campa A, Gaseitsiwe S, Bussmann H, Makhema J, Marlink R, Novitsky V, Lee TH, Cai T, O'Brien SJ, Essex M.

AIDS Res Hum Retroviruses. 2017 Jun;33(6):597-609. doi: 10.1089/AID.2016.0017. Epub 2017 Apr 6.

11.

Slow CD4+ T-Cell Recovery in Human Immunodeficiency Virus/Hepatitis B Virus-Coinfected Patients Initiating Truvada-Based Combination Antiretroviral Therapy in Botswana.

Anderson M, Gaseitsiwe S, Moyo S, Thami KP, Mohammed T, Setlhare D, Sebunya TK, Powell EA, Makhema J, Blackard JT, Marlink R, Essex M, Musonda RM.

Open Forum Infect Dis. 2016 Aug 16;3(3):ofw140. eCollection 2016 Sep.

12.

Impact of Health System Inputs on Health Outcome: A Multilevel Longitudinal Analysis of Botswana National Antiretroviral Program (2002-2013).

Farahani M, Price N, El-Halabi S, Mlaudzi N, Keapoletswe K, Lebelonyane R, Fetogang EB, Chebani T, Kebaabetswe P, Masupe T, Gabaake K, Auld AF, Nkomazana O, Marlink R.

PLoS One. 2016 Aug 4;11(8):e0160206. doi: 10.1371/journal.pone.0160206. eCollection 2016.

13.

Short Communication: Low False Recent Rate of Limiting Antigen-Avidity Assay Combined with HIV-1 RNA Data in Botswana.

Moyo S, Kotokwe KP, Mohammed T, Boleo C, Mupfumi L, Chishala S, Tsalaile L, Bussmann H, Gaseitsiwe S, Musonda R, Makhema J, Baum M, Marlink R, Engelbrecht S, Essex M, Novitsky V.

AIDS Res Hum Retroviruses. 2017 Jan;33(1):17-18. doi: 10.1089/AID.2016.0127. Epub 2016 Sep 7.

14.

Wide Variations in Compliance with Tuberculosis Screening Guidelines and Tuberculosis Incidence between Antiretroviral Therapy Facilities - Côte d'Ivoire.

Auld AF, Blain M, Ekra KA, Kouakou JS, Ettiègne-Traoré V, Tuho MZ, Mohamed F, Shiraishi RW, Sabatier J, Essombo J, Adjorlolo-Johnson G, Marlink R, Ellerbrock TV.

PLoS One. 2016 Jun 8;11(6):e0157059. doi: 10.1371/journal.pone.0157059. eCollection 2016.

15.

Effect of BMI and fat mass on HIV disease progression in HIV-infected, antiretroviral treatment-naïve adults in Botswana.

Martinez SS, Campa A, Bussmann H, Moyo S, Makhema J, Huffman FG, Williams OD, Essex M, Marlink R, Baum MK.

Br J Nutr. 2016 Jun;115(12):2114-21. doi: 10.1017/S0007114516001409. Epub 2016 Apr 18.

16.

Prevalence and distribution of non-AIDS causes of death among HIV-infected individuals receiving antiretroviral therapy: a systematic review and meta-analysis.

Farahani M, Mulinder H, Farahani A, Marlink R.

Int J STD AIDS. 2017 Jun;28(7):636-650. doi: 10.1177/0956462416632428. Epub 2016 Feb 10. Review.

PMID:
26868158
17.

How providers influence the implementation of provider-initiated HIV testing and counseling in Botswana: a qualitative study.

Ahmed S, Bärnighausen T, Daniels N, Marlink R, Roberts MJ.

Implement Sci. 2016 Feb 11;11:18. doi: 10.1186/s13012-015-0361-7.

18.

Recruitment, Follow-Up and Characteristics of HIV Infected Adults who Use Illicit Drugs in Southern Africa.

Baum MK, Campa A, Page JB, Lai S, Tsalaile L, Martinez SS, Burns P, Williams O, Li Y, van Widenfelt E, Bussmann H, Sikhulele M, Makhema J, Essex M, Marlink R.

J Drug Abuse. 2015;1(1). pii: 7. Epub 2015 Dec 8.

19.

Prognostic Value of HIV-1 RNA on CD4 Trajectories and Disease Progression Among Antiretroviral-Naive HIV-Infected Adults in Botswana: A Joint Modeling Analysis.

Farahani M, Novitsky V, Wang R, Bussmann H, Moyo S, Musonda RM, Moeti T, Makhema JM, Essex M, Marlink R.

AIDS Res Hum Retroviruses. 2016 Jun;32(6):573-8. doi: 10.1089/AID.2015.0348. Epub 2016 Mar 3.

20.

Trends and determinants of survival for over 200 000 patients on antiretroviral treatment in the Botswana National Program: 2002-2013.

Farahani M, Price N, El-Halabi S, Mlaudzi N, Keapoletswe K, Lebelonyane R, Fetogang EB, Chebani T, Kebaabetswe P, Masupe T, Gabaake K, Auld A, Nkomazana O, Marlink R.

AIDS. 2016 Jan 28;30(3):477-85. doi: 10.1097/QAD.0000000000000921.

21.

Lower Levels of Antiretroviral Therapy Enrollment Among Men with HIV Compared with Women - 12 Countries, 2002-2013.

Auld AF, Shiraishi RW, Mbofana F, Couto A, Fetogang EB, El-Halabi S, Lebelonyane R, Pilatwe PT, Hamunime N, Okello V, Mutasa-Apollo T, Mugurungi O, Murungu J, Dzangare J, Kwesigabo G, Wabwire-Mangen F, Mulenga M, Hachizovu S, Ettiegne-Traore V, Mohamed F; MSAE, Bashorun A, Nhan do T, Hai NH, Quang TH, Van Onacker JD, Francois K, Robin EG, Desforges G, Farahani M, Kamiru H, Nuwagaba-Biribonwoha H, Ehrenkranz P, Denison JA, Koole O, Tsui S, Torpey K, Mukadi YD, van Praag E, Menten J, Mastro TD, Hamilton CD, Abiri OO, Griswold M, Pierre E, Xavier C, Alfredo C, Jobarteh K, Letebele M, Agolory S, Baughman AL, Mutandi G, Preko P, Ryan C, Ao T, Gonese E, Herman-Roloff A, Ekra KA, Kouakou JS, Odafe S, Onotu D, Dalhatu I, Debem HH, Nguyen DB, Yen le N, Abdul-Quader AS, Pelletier V, Williams SG, Behel S, Bicego G, Swaminathan M, Dokubo EK, Adjorlolo-Johnson G, Marlink R, Lowrance D, Spira T, Colebunders R, Bangsberg D, Zee A, Kaplan J, Ellerbrock TV.

MMWR Morb Mortal Wkly Rep. 2015 Nov 27;64(46):1281-6. doi: 10.15585/mmwr.mm6446a2.

22.

Variation in attrition at subnational level: review of the Botswana National HIV/AIDS Treatment (Masa) programme data (2002-2013).

Farahani M, Price N, El-Halabi S, Mlaudzi N, Keapoletswe K, Lebelonyane R, Fetogang EB, Chebani T, Kebaabetswe P, Masupe T, Gabaake K, Auld A, Nkomazana O, Marlink R.

Trop Med Int Health. 2016 Jan;21(1):18-27. doi: 10.1111/tmi.12623. Epub 2015 Nov 12.

23.

Plasma Cytokine Levels in Chronic Asymptomatic HIV-1 Subtype C Infection as an Indicator of Disease Progression in Botswana: A Retrospective Case Control Study.

Iketleng T, Moyo S, Gaseitsiwe S, Nyombi B, Mitchell RM, Makhema J, Baum MK, Marlink R, Essex M, Musonda R.

AIDS Res Hum Retroviruses. 2016 Apr;32(4):364-9. doi: 10.1089/AID.2015.0163. Epub 2015 Oct 21.

24.

Personal views about womanhood amongst women living with HIV in Botswana.

Schaan MM, Taylor M, Gungqisa N, Marlink R.

Cult Health Sex. 2016;18(2):173-85. doi: 10.1080/13691058.2015.1072247. Epub 2015 Aug 25.

PMID:
26305285
25.

Molecular characterisation of hepatitis B virus in HIV-1 subtype C infected patients in Botswana.

Anderson M, Gaseitsiwe S, Moyo S, Wessels MJ, Mohammed T, Sebunya TK, Powell EA, Makhema J, Blackard JT, Marlink R, Essex M, Musonda RM.

BMC Infect Dis. 2015 Aug 13;15:335. doi: 10.1186/s12879-015-1096-4.

26.

Antiretroviral therapy enrollment characteristics and outcomes among HIV-infected adolescents and young adults compared with older adults--seven African countries, 2004-2013.

Auld AF, Agolory SG, Shiraishi RW, Wabwire-Mangen F, Kwesigabo G, Mulenga M, Hachizovu S, Asadu E, Tuho MZ, Ettiegne-Traore V, Mbofana F, Okello V, Azih C, Denison JA, Tsui S, Koole O, Kamiru H, Nuwagaba-Biribonwoha H, Alfredo C, Jobarteh K, Odafe S, Onotu D, Ekra KA, Kouakou JS, Ehrenkranz P, Bicego G, Torpey K, Mukadi YD, van Praag E, Menten J, Mastro T, Dukes Hamilton C, Swaminathan M, Dokubo EK, Baughman AL, Spira T, Colebunders R, Bangsberg D, Marlink R, Zee A, Kaplan J, Ellerbrock TV.

MMWR Morb Mortal Wkly Rep. 2014 Nov 28;63(47):1097-103.

27.

Reproductive behaviour among women on antiretroviral therapy in Botswana: mismatched pregnancy plans and contraceptive use.

Schaan MM, Taylor M, Marlink R.

Afr J AIDS Res. 2014 Sep;13(3):305-11. doi: 10.2989/16085906.2014.952654.

PMID:
25388984
28.

Pregnancy outcomes and birth defects from an antiretroviral drug safety study of women in South Africa and Zambia.

Liu KC, Farahani M, Mashamba T, Mawela M, Joseph J, Van Schaik N, Honey E, Gill M, Jassat W, Stringer EM, Chintu N, Marlink RG.

AIDS. 2014 Sep 24;28(15):2259-68. doi: 10.1097/QAD.0000000000000394.

29.

Outcomes of the Botswana national HIV/AIDS treatment programme from 2002 to 2010: a longitudinal analysis.

Farahani M, Vable A, Lebelonyane R, Seipone K, Anderson M, Avalos A, Chadborn T, Tilahun H, Roumis D, Moeti T, Musuka G, Busang L, Gaolathe T, Malefho KC, Marlink R.

Lancet Glob Health. 2014 Jan;2(1):e44-50. doi: 10.1016/S2214-109X(13)70149-9. Epub 2013 Dec 11.

30.

Temporal trends in mortality and loss to follow-up among children enrolled in Côte d'Ivoire's national antiretroviral therapy program.

Auld AF, Tuho MZ, Ekra KA, Shiraishi RW, Mohamed F, Kouakou JS, Ettiègne-Traoré V, Sabatier J, Essombo J, Rivadeneira ED, Adjorlolo-Johnson G, Marlink R, Ellerbrock TV.

Pediatr Infect Dis J. 2014 Nov;33(11):1134-40. doi: 10.1097/INF.0000000000000457.

PMID:
25093975
31.

Temporal trends in treatment outcomes for HIV-1 and HIV-2-infected adults enrolled in Côte d'Ivoire's national antiretroviral therapy program.

Auld AF, Ekra KA, Shiraishi RW, Tuho MZ, Kouakou JS, Mohamed F, Ettiègne-Traoré V, Sabatier J, Essombo J, Adjorlolo-Johnson G, Marlink R, Ellerbrock TV.

PLoS One. 2014 May 27;9(5):e98183. doi: 10.1371/journal.pone.0098183. eCollection 2014.

32.

Tuberculosis in human immunodeficiency virus-infected children starting antiretroviral therapy in Côte d'Ivoire.

Auld AF, Tuho MZ, Ekra KA, Kouakou J, Shiraishi RW, Adjorlolo-Johnson G, Marlink R, Ellerbrock TV.

Int J Tuberc Lung Dis. 2014 Apr;18(4):381-7. doi: 10.5588/ijtld.13.0395.

PMID:
24670690
33.

Effect of micronutrient supplementation on disease progression in asymptomatic, antiretroviral-naive, HIV-infected adults in Botswana: a randomized clinical trial.

Baum MK, Campa A, Lai S, Sales Martinez S, Tsalaile L, Burns P, Farahani M, Li Y, van Widenfelt E, Page JB, Bussmann H, Fawzi WW, Moyo S, Makhema J, Thior I, Essex M, Marlink R.

JAMA. 2013 Nov 27;310(20):2154-63. doi: 10.1001/jama.2013.280923.

34.

Evaluation of the false recent classification rates of multiassay algorithms in estimating HIV type 1 subtype C incidence.

Moyo S, LeCuyer T, Wang R, Gaseitsiwe S, Weng J, Musonda R, Bussmann H, Mine M, Engelbrecht S, Makhema J, Marlink R, Baum MK, Novitsky V, Essex M.

AIDS Res Hum Retroviruses. 2014 Jan;30(1):29-36. doi: 10.1089/AID.2013.0055. Epub 2013 Sep 6.

35.

Persistently elevated serum interleukin-6 predicts mortality among adults receiving combination antiretroviral therapy in Botswana: results from a clinical trial.

McDonald B, Moyo S, Gabaitiri L, Gaseitsiwe S, Bussmann H, Koethe JR, Musonda R, Makhema J, Novitsky V, Marlink RG, Wester CW, Essex M.

AIDS Res Hum Retroviruses. 2013 Jul;29(7):993-9. doi: 10.1089/AID.2012.0309. Epub 2013 May 9.

36.

HIV-Related knowledge, attitudes, and practice among educated young adults in Botswana.

Stephens LL, Bachhuber MA, Seloilwe E, Gungqisa N, Mmelesi M, Bussmann H, Marlink RG, Wester CW.

J AIDS HIV Res. 2012 Jun 1;4(6):159-164.

37.

How the global call for elimination of pediatric HIV can support HIV-positive women to achieve their pregnancy intentions.

Mazzeo CI, Flanagan EH, Bobrow EA, Pitter CS, Marlink R.

Reprod Health Matters. 2012 Dec;20(39 Suppl):90-102. doi: 10.1016/S0968-8080(12)39636-5. Review.

38.

Validation of A Point-of-Care Lactate Device For Screening At-Risk Adults Receiving Combination Antiretroviral Therapy In Botswana.

Moyo S, Bussmann H, Mangwendeza P, Dusara P, Gaolathe T, Mine M, Musonda R, van Widenfelt E, Novitsky V, Makhema J, Marlink RG, Essex M, Wester CW.

J Antivir Antiretrovir. 2011 Oct;3(4):45-48. Epub 2011 Sep 20.

39.

Scaling up pediatric HIV care and treatment in Africa: clinical site characteristics associated with favorable service utilization.

Adjorlolo-Johnson G, Wahl Uheling A, Ramachandran S, Strasser S, Kouakou J, Tindyebwa D, Alons C, Neluheni T, Lee S, Marlink R.

J Acquir Immune Defic Syndr. 2013 Jan 1;62(1):e7-e13. doi: 10.1097/QAI.0b013e3182706401.

PMID:
22955053
40.

Engaging to end the epidemic: seven essential steps toward an AIDS-free generation.

Marlink R, El-Sadr W, Simao M, Katabira E.

J Acquir Immune Defic Syndr. 2012 Aug 1;60 Suppl 2:S19-21. doi: 10.1097/QAI.0b013e31826028d5. No abstract available.

PMID:
22772384
41.

Sexual and reproductive health needs of HIV-positive women in Botswana - a study of health care worker's views.

Schaan MM, Taylor M, Puvimanasinghe J, Busang L, Keapoletswe K, Marlink R.

AIDS Care. 2012;24(9):1120-5. doi: 10.1080/09540121.2012.672814. Epub 2012 May 9.

PMID:
22568549
42.

Risk factors for symptomatic hyperlactatemia and lactic acidosis among combination antiretroviral therapy-treated adults in Botswana: results from a clinical trial.

Wester CW, Eden SK, Shepherd BE, Bussmann H, Novitsky V, Samuels DC, Hendrickson SL, Winkler CA, O'Brien SJ, Essex M, D'Aquila RT, DeGruttola V, Marlink RG.

AIDS Res Hum Retroviruses. 2012 Aug;28(8):759-65. doi: 10.1089/AID.2011.0303. Epub 2012 Jun 1.

43.

Gender-sensitive reporting in medical research.

Heidari S, Abdool Karim Q, Auerbach JD, Buitendijk SE, Cahn P, Curno MJ, Hankins C, Katabira E, Kippax S, Marlink R, Marsh J, Marusic A, Nass HM, Montaner J, Pollitzer E, Ruiz-Cantero MT, Sherr L, Sow PS, Squires K, Wainberg MA.

J Int AIDS Soc. 2012 Mar 8;15(1):11. doi: 10.1186/1758-2652-15-11.

44.

Effect modification by sex and baseline CD4+ cell count among adults receiving combination antiretroviral therapy in Botswana: results from a clinical trial.

Wester CW, Stitelman OM, deGruttola V, Bussmann H, Marlink RG, van der Laan MJ.

AIDS Res Hum Retroviruses. 2012 Sep;28(9):981-8. doi: 10.1089/AID.2011.0349. Epub 2012 Mar 23.

45.

Immunohaematological reference values for HIV-negative healthy adults in Botswana.

Mine M, Moyo S, Stevens P, Michael K, Novitsky V, Makhaola K, Asmelash A, Molefhabangwe S, Woldegabriel E, Mothowaeng G, Maruta T, Kamhukamwe C, Mangwendeza PM, Holmes-Pretorius M, Mtoni I, Motswaledi M, Musonda R, Ndwapi N, Makhema J, Marlink R, Seipone K, Gaolathe T, Essex M.

Afr J Lab Med. 2012;1(1). pii: 5. doi: 10.4102/ajlm.v1i1.5.

46.

Immunohaematological reference values for HIV-negative healthy adults in Botswana.

Mine M, Moyo S, Stevens P, Michael K, Novitsky V, Makhaola K, Asmelash A, Molefhabangwe S, Woldegabriel E, Mothowaeng G, Maruta T, Kamhukamwe C, Mangwendeza PM, Holmes-Pretorius M, Mtoni I, Motswaledi M, Musonda R, Ndwapi N, Makhema J, Marlink R, Seipone K, Gaolathe T, Essex M.

Afr J Lab Med. 2011 Dec 15;1(1):5. doi: 10.4102/ajlm.v1i1.5. eCollection 2012.

PMID:
29062725
47.

Unresolved antiretroviral treatment management issues in HIV-infected children.

Heidari S, Mofenson LM, Hobbs CV, Cotton MF, Marlink R, Katabira E.

J Acquir Immune Defic Syndr. 2012 Feb 1;59(2):161-9. doi: 10.1097/QAI.0b013e3182427029. Review.

48.

Antiretroviral drugs for preventing mother-to-child transmission of HIV: a review of potential effects on HIV-exposed but uninfected children.

Heidari S, Mofenson L, Cotton MF, Marlink R, Cahn P, Katabira E.

J Acquir Immune Defic Syndr. 2011 Aug 1;57(4):290-6. doi: 10.1097/QAI.0b013e318221c56a. Review.

PMID:
21602695
49.

Non-AIDS-defining events among HIV-1-infected adults receiving combination antiretroviral therapy in resource-replete versus resource-limited urban setting.

Wester CW, Koethe JR, Shepherd BE, Stinnette SE, Rebeiro PF, Kipp AM, Hong H, Bussmann H, Gaolathe T, McGowan CC, Sterling TR, Marlink RG.

AIDS. 2011 Jul 31;25(12):1471-9. doi: 10.1097/QAD.0b013e328347f9d4.

50.

Prevalence of transmitted HIV drug resistance in Botswana: lessons learned from the HIVDR-Threshold Survey conducted among women presenting for routine antenatal care as part of the 2007 national sentinel survey.

Bussmann H, de la Hoz Gomez F, Roels TH, Wester CW, Bodika SM, Moyo S, Taffa N, Anderson MG, Mine M, Bile EC, Yang C, Mphoyakgosi K, Lehotzky EA, Mlotshwa B, Mmelesi M, Seipone K, Makhema MJ, Marlink RG, Novitsky V, Essex M.

AIDS Res Hum Retroviruses. 2011 Apr;27(4):365-72. doi: 10.1089/aid.2010.0273. Epub 2010 Oct 29.

PMID:
21034246

Supplemental Content

Loading ...
Support Center